Altered Levels of Interleukins and Neurotrophic Growth Factors in Mood Disorders and Suicidality: an Analysis from Periphery to Central Nervous System

Overview

Journal Transl Psychiatry

Specialties Psychiatry
Public Health

Date 2021 Jun 3

PMID 34078872

Citations 17

Authors

Bharathi S Gadad

Javier Vargas-Medrano

Enrique Ivan Ramos

Katherine Najera

Matthew Fagan

Angelica Forero

Peter M Thompson

Affiliations

Soon will be listed here.

Abstract

Interleukins and neurotrophins levels are altered in the periphery of patients with major depression and suicidal behavior, however it is not clear if similar abnormalities occur in the central nervous system. Our objective was to examine the association of IL-6, IL-1β, BDNF, and GDNF levels between postmortem plasma, cerebrospinal fluid (CSF), and brain tissue in a heterogeneous diagnostic subject groups including normal controls, mood disorders only, mood disorders with AUD/SUD (alcohol abuse disorder, substance abuse disorder), and AUD/SUD without mood disorders. To address these questions we collected postmortem plasma (n = 29), CSF (n = 28), and brain (BA10) (n = 57) samples from individuals with mood disorder, mood disorder with AUD/SUD, AUD/SUD and normal controls. These samples were analyzed using a multiplex based luminex assay with a customized 4-plex cytokine/interleukins- IL-6, IL-1β, BDNF, and GDNF human acute phase based on xMAP technology platform. Protein levels were determined using a Luminex 200 instrument equipped with Xponent-analyzing software. We observed IL-6 (p = 2.1e-07), and GDNF (p = 0.046) were significantly correlated between brain and CSF. In addition, IL-6 (p = 0.031), were significantly correlated between brain and plasma. Overall diagnostic group analysis showed a significant difference with brain GDNF, p = 0.0106. Pairwise comparisons showed that GDNF level is-39.9 ± 12 pg/ml, p = 0.0106, was significantly higher than in the brains derived from mood disorders compared to normal controls, -23.8 ± 5.5 pg/ml, p = 0.034. Brain BDNF was higher in suicide (p = 0.0023), males compared to females (p = 0.017), and psychiatric medication treated vs. non-treated (p = 0.005) individuals. Overall, we demonstrate that blood IL-6, GDNF and BDNF could be informative peripheral biomarkers of brain biology associated with mood disorders, substance disorders, and suicide.

Citing Articles

Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression.

Sun S, Han Y, Liu X, Yang L, Han T, Lin Y Front Neurol. 2024; 15:1480854.

PMID: 39474368 PMC: 11518734. DOI: 10.3389/fneur.2024.1480854.

The forensic aspects of suicide and neurotrophin factors: a research study.

De Simone S, Alfieri L, Bosco M, Cantatore S, Carpinteri M, Cipolloni L Front Pharmacol. 2024; 15:1392832.

PMID: 39170712 PMC: 11335659. DOI: 10.3389/fphar.2024.1392832.

Inflammation and immune system pathways as biological signatures of adolescent depression-the IDEA-RiSCo study.

Zonca V, Marizzoni M, Saleri S, Zajkowska Z, Manfro P, Souza L Transl Psychiatry. 2024; 14(1):230.

PMID: 38824135 PMC: 11144232. DOI: 10.1038/s41398-024-02959-z.

Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients.

Guo Z, Long T, Yao J, Li Y, Xiao L, Chen M Front Pharmacol. 2024; 15:1337876.

PMID: 38628641 PMC: 11019007. DOI: 10.3389/fphar.2024.1337876.

Concordance between the In Vivo Content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and Blood in Patients with Epilepsy.

Tikhonova M, Shvaikovskaya A, Zhanaeva S, Moysak G, Akopyan A, Rzaev J Int J Mol Sci. 2024; 25(1).

PMID: 38203674 PMC: 10779095. DOI: 10.3390/ijms25010502.

References

Munkholm K, Brauner J, Kessing L, Vinberg M . Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013; 47(9):1119-33. DOI: 10.1016/j.jpsychires.2013.05.018. View

Frommberger U, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M . Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci. 1997; 247(4):228-33. DOI: 10.1007/BF02900219. View

Klein A, Williamson R, Santini M, Clemmensen C, Ettrup A, Rios M . Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2010; 14(3):347-53. DOI: 10.1017/S1461145710000738. View

Tonelli L, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K . Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 2007; 117(3):198-206. PMC: 2612100. DOI: 10.1111/j.1600-0447.2007.01128.x. View

Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L . Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry. 2009; 66(3):287-92. DOI: 10.1016/j.biopsych.2009.01.030. View

Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L . Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun. 2010; 25(2):335-9. DOI: 10.1016/j.bbi.2010.10.010. View

Molnar M, Potkin S, Bunney W, Jones E . MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol Psychiatry. 2003; 53(1):39-47. DOI: 10.1016/s0006-3223(02)01456-7. View

Bergmans R, Kelly K, Mezuk B . Inflammation as a unique marker of suicide ideation distinct from depression syndrome among U.S. adults. J Affect Disord. 2019; 245:1052-1060. PMC: 6448785. DOI: 10.1016/j.jad.2018.11.046. View

Chen B, Dowlatshahi D, MacQueen G, Wang J, Young L . Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001; 50(4):260-5. DOI: 10.1016/s0006-3223(01)01083-6. View

10.

Felger J, Lotrich F . Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013; 246:199-229. PMC: 3741070. DOI: 10.1016/j.neuroscience.2013.04.060. View

11.

Michel T, Frangou S, Camara S, Thiemeyer D, Jecel J, Tatschner T . Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry. 2008; 23(6):413-20. DOI: 10.1016/j.eurpsy.2008.06.001. View

12.

Qin L, He J, Hanes R, Pluzarev O, Hong J, Crews F . Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation. 2008; 5:10. PMC: 2373291. DOI: 10.1186/1742-2094-5-10. View

13.

Black C, Miller B . Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients. Biol Psychiatry. 2014; 78(1):28-37. DOI: 10.1016/j.biopsych.2014.10.014. View

14.

Zhang X, Zhang Z, Sha W, Xie C, Xi G, Zhou H . Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Res. 2009; 170(2-3):273-5. DOI: 10.1016/j.psychres.2009.01.011. View

15.

Sims C, Hofmann J, Anderson L, Shore A, Torrey E, Yolken R . Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry. 2000; 5(2):142-9. DOI: 10.1038/sj.mp.4000696. View

16.

Crews F, Bechara R, Brown L, Guidot D, Mandrekar P, Oak S . Cytokines and alcohol. Alcohol Clin Exp Res. 2006; 30(4):720-30. DOI: 10.1111/j.1530-0277.2006.00084.x. View

17.

Miller A, Maletic V, Raison C . Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65(9):732-41. PMC: 2680424. DOI: 10.1016/j.biopsych.2008.11.029. View

18.

Schiepers O, Wichers M, Maes M . Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(2):201-17. DOI: 10.1016/j.pnpbp.2004.11.003. View

19.

Molendijk M, Bus B, Spinhoven P, Penninx B, Kenis G, Prickaerts J . Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2010; 16(11):1088-95. PMC: 3220395. DOI: 10.1038/mp.2010.98. View

20.

Park Y, Lee B . Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder. Psychiatry Investig. 2018; 15(8):818-823. PMC: 6111227. DOI: 10.30773/pi.2018.03.31. View